The world is betting on one thing to halt the pandemic: A vaccine. This is what it will take to bring one to the masses.
£84 million of government funding towards the British vaccine candidates at Oxford University and Imperial College London. The bulk of the funding, £65.5 million , will go towards the Oxford candidate.
The Oxford vaccine -- among the most closely-watched and highly-anticipated efforts -- has also received investments from the EU and the US. But the British government has secured early access to aroundEurope’s Inclusive Vaccines Alliance -- spearheaded by France, Germany, Italy and the Netherlands -- has struck a deal for up toThe US has made a similar deal with AstraZeneca forIf the US and Europe have merely hinted that they’ll prioritize their people first for vaccines, China has made no secret of its plan to do exactly that., the decision-making body of WHO, in May that Beijing would help provide a vaccine globally, but only after it had been deployed in China. US health officials say America, the G7, the EU and the ACT Accelerator are collaborating closely on vaccine development -- but not China. “I believe they're just -- they're doing their own thing,”China has a shorter history of vaccine expertise compared to the US and Europe, but it has size on its side. It is the world’s largest producer and consumer of vaccines and can supply more than 1 billion doses of a vaccine annually from 40 manufacturers across the country, according to theChinese President Xi Jinping assesses the progress on vaccine and antibody research during his visit to the Academy of Military Medical Sciences in Beijing on March 2.Of the 29 vaccines currently in human trials globally, nine are from China -- the most from any country by a long shot. And three of the six vaccine candidates in late-stage trials are being developed by Chinese companies Sinovac and Sinopharm.that it could have a vaccine ready for public use by the end of the year.But Beijing is determined to shake this image.said Chinese scientists and officials were collaborating with international partners, medical institutions and experts to ensure transparency around their vaccine efforts. It also said that although vaccine research and development had been dramatically accelerated, Beijing was adhering to safety principles.But the question remains: Will leaders -- the world over -- be able to respond and buy the vaccine for their own populations if one of the big three efforts succeeds? And will poorer nations once again be left behind? It is this concern that prompted Dr. Seth Berkley, CEO of Gavi, the Vaccine Alliance, to call for an international accord to ensure poorer countries get access to the vaccine. The best-case chance of getting a vaccine, according to Berkley, is adopting the collaborative approach that was used in the race for an Ebola vaccine -- a process which began in the Canadian Public Health laboratory, was transferred to an American biotech firm, then an American multinational company, and finally to a German company for manufacturing.A lab technician looks at a bottle containing a reagent, before performing vaccine tests at Sanofi's laboratory in Val de Reuil, France, on July 10.Restricting the effort to a national lab or set of scientists or certain company won’t deliver the best vaccine -- and it certainly won’t allow it to be distributed to all -- he added. There are some promising signs of international cooperation. Aside from WHO’s ACT Accelerator initiative, the
Please follow us on Google to support us United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
How a college with zero COVID-19 cases in 3 months safely reopenedThis community college in Ohio has had no reported cases of COVID-19 traced to the school since reopening for in-person classes three months ago.
Read more »
Covid-19 is causing a microcredit crunchWithout this form of finance, covid-19 means more people in need will turn to loan sharks. They risk falling into debt spirals
Read more »
US airlines are banning vented masks, which the CDC says don't stop COVID-19 - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »
COVID-19 Supply Crunch Means More Testing DelaysThe lack of supplies for doing enough COVID-19 diagnostic testing within a useful turnaround time will likely last and will continue to hamper the nation's response to the pandemic, according to public health experts and health care professionals. More:
Read more »
Inside the multibillion dollar race for a Covid-19 vaccineThe world is betting on one thing to halt the pandemic: A vaccine. This is what it will take to bring one to the masses — and the key players behind those efforts.
Read more »
Inside the multibillion dollar race for a Covid-19 vaccineThe world is betting on one thing to stop the pandemic: A vaccine. This is what it will take to bring one to the masses — and the key players behind those efforts.
Read more »